Apexigen, Inc.
APGNDelisted Aug 23, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001814140
Apexigen, Inc. was delisted on Aug 23, 2023; its insiders filed their last Form 4 on Aug 25, 2023; 17 institutions reported holding it in 13F filings for Q2 2023, worth $1.37M in total; no superinvestor held it.
13F holders, Q2 2023
Institutional positions in Apexigen, Inc. as of Jun 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
APGN is no longer listed, so this page shows Q2 2023. 13F filings for later quarters list far fewer holders.
- Institutional holders
- 17
- −3 vs. Q1 2023
- Shares held
- 3.19M
- −176.9K (−5.3%) vs. Q1 2023
- Total value
- $1.37M
- −$273.3K (−16.6%) vs. Q1 2023
- New holders
- 1
- 4 more added
- Sold out
- 4
- 3 more reduced
Compare with Q1 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting APGN on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 0 | $0 |
| Q4 2023 | 0 | $0 |
| Q3 2023 | 0 | $0 |
| Q2 2023 | 17 | $1.37M |
| Q1 2023 | 20 | $1.64M |
| Q4 2022 | 15 | $2.16M |
| Q3 2022 | 17 | $8.48M |
| Q2 2022 | 1 | $912.0K |
| Q1 2022 | 0 | $0 |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q2 2023
Shares, value and share of portfolio for each institution holding Apexigen, Inc.; share changes are against Q1 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Decheng Capital Management III (Cayman), LLC | 1,894,551 | $814.3K | 0.26% | 00.0% | Unchanged |
| Fan Yu | 401,757 | $172.7K | 13.54% | 00.0% | Unchanged |
| Vanguard Group Inc | 256,935 | $110.4K | 0.00% | 00.0% | Unchanged |
| BlackRock Inc. | 213,833 | $91.9K | 0.00% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 178,760 | $76.8K | 0.00% | 00.0% | Unchanged |
| State Street Corp | 54,300 | $23.3K | 0.00% | 00.0% | Unchanged |
| Mercer Global Advisors Inc | 43,626 | $19.0K | 0.00% | 00.0% | Unchanged |
| Renaissance Technologies LLC | 44,150 | $19.0K | 0.00% | +29,338+198.1% | Added |
| Northern Trust Corp | 31,041 | $13.3K | 0.00% | 00.0% | Unchanged |
| Two Sigma Investments, LP | 17,006 | $7.31K | 0.00% | −11,964−41.3% | Reduced |
| Two Sigma Securities, LLC | 14,233 | $6.12K | 0.00% | −13,889−49.4% | Reduced |
| Destination Wealth Management | 13,216 | $5.68K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 12,106 | $5.21K | 0.00% | +348+3.0% | Added |
| JBF Capital, Inc. | 9,130 | $3.92K | 0.00% | +9,130 | New |
| Simplex Trading, LLC | 3,308 | $1.00K | 0.00% | +2,280+221.8% | Added |
| Wells Fargo & Company | 154 | $66 | 0.00% | +6+4.1% | Added |
| Cutler Group LP | 300 | $0 | 0.00% | −500−62.5% | Reduced |
| CVI Holdings, LLC | 0 | $0 | 0.00% | −150,000−100.0% | Sold out |
| Millennium Management LLC | 0 | $0 | 0.00% | −21,771−100.0% | Sold out |
| Susquehanna International Group, LLP | 0 | $0 | 0.00% | −15,546−100.0% | Sold out |
| UBS Group AG | 0 | $0 | 0.00% | −4,376−100.0% | Sold out |